12 Biotech Concepts Everyone Should Know

Emily BurkeBiologics, Biotech Basics, Business of Biotech, Cancer, Cardiovascular Disease, Clinical Trials, Diabetes, Diagnostics, Drug Approvals, Drug Development, Drug Targets, Ebola, FDA, Genetics, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY

Our mission here at WEEKLY is to keep your industry knowledge up to date. We will be off Thursday, roasting our turkeys and reminding ourselves that it is not the amino acid tryptophan that makes us drowsy after a Thanksgiving feast—it is the massive carbohydrate intake! Whether you are awaiting a Thanksgiving holiday or it is business as usual, we … Read More

Pioneers In The Land Of Small Proteins

Emily BurkeBiologics, Biotech Basics, Business of Biotech, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, The WEEKLY

We continue last week’s trek into the IPO wilderness to explore the technology of Molecular Partners (Zurich, Switzerland). What they are in search of is a new class of small protein therapeutics, referred to by their acronym: DARPins. DARPins inherently share some of the same advantages monoclonal antibodies (mAbs) have over small molecule drugs. DARPins go a step further and offer possible … Read More

Driving Down The Epigenetic Highway

Emily BurkeBusiness of Biotech, Cancer, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, FDA, Genetics, Genomics, The WEEKLY

Biotechnology is enjoying another banner year on Wall Street. Currently, there are at least 39 companies queued for an IPO. This led us at the WEEKLY to wonder: what is the actual science behind each company’s promise that leads public markets to invest billions of dollars? This week and next, we are popping open the hood and checking out what … Read More

Breaking From The Pack With Cancer Diagnostics

Emily BurkeBiologics, Cancer, Cocktail Fodder, Diagnostics, Monoclonal Antibodies, The WEEKLY

Regular WEEKLY readers know that cancer stems from the division of a single cell leaping to uncontrolled growth and then growing into a tumor. How exactly does cancer disrupt the life process? Sometimes tumors grow to such a size that the function of a vital organ is no longer viable. Mostly, cancer kills by metastasis—when cells from the tumor break … Read More